In this study, we have shown that the novel halohydroxy dimeric naphthoquinones BiQ-1 and BiQ-2 have low micromolar potency against both FLT3-WT and FLT3-ITD AML cell lines and primary cells from patients with AML. Here, FLT3 is linked to acute myeloid leukemia.